Helix BiopharmaHBP 
$0.7014.94%24h
14.94%24h
Global rank18217
Market cap$135.74M
Change 7d8.70%
YTD Performance376.19%
SP500 benchmarkOutperform
P/E-23.42
P/S0
Revenue$0
Earnings-$4.42M
Dividend yield-
Main Sector
Healthcare
Helix Biopharma (HBP) Cash on Hand
HBP Cash on Hand in 2022: $567.60K
According to Helix Biopharma latest financial reports the cash on hand of HBP is $567.60K, an decrease of -75.15% to 2022. At the end of 2022 company had $2.28M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
HBP Cash on Hand History from 2019 to 2023
-
Value:-
HBP Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $567.60K | -75.15% |
| 2022 | $2.28M | -8.78% |
| 2021 | $2.50M | -15.82% |
| 2020 | $2.97M | 1955.83% |
| 2019 | $144.71K | - |
View the Top Cash on Hand Companies 
